ReviewCurrent hematologic malignancy reports2024

Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions.

Delphine Rea et al.PubMed ↗Publisher ↗

No numbers read from the abstract.